@article{article, title = {{UPDATED EFFICACY AND SAFETY OF ORAL ERDAFITINIB IN PATIENTS WITH BACILLUS CALMETTE-GU脡RIN鈥揢NRESPONSIVE, HIGH-RISK NON-MUSCLE鈥揑NVASIVE BLADDER CANCER WITH FGFR3/2 ALTERATIONS IN THOR-2 COHORT 2}}, publisher = {{Elsevier BV}}, url = {{http://dx.doi.org/10.1016/j.urolonc.2024.01.161 }}, year = {{2024}}, month = {{3}}, author = {{Catto JWF and Hussain SA and Tran B and Pignot G and Master V and Roupr锚t M and Tubaro A and Shimizu N and Vasdev N and Nishiyama H and Daneshmand S et al}}, doi = {{10.1016/j.urolonc.2024.01.161}}, volume = {{42}}, journal = {{Urologic Oncology: Seminars and Original Investigations}}, pages = {{S53-S53}}, note = {{Accessed on 2025/07/18}}}